Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 474

The DOI matches its Crossref record.

Lipopeptides from Bacillus and Paenibacillus spp.: A Gold Mine of Antibiotic Candidates

Cochrane, Stephen A., Vederas, John C.·2016·Medicinal Research Reviews

Abstract

The emergence of multidrug‐resistant bacteria has placed a strain on health care systems and highlighted the need for new classes of antibiotics. Bacterial lipopeptides are secondary metabolites, generally produced by nonribosomal peptide synthetases that often exhibit broad‐spectrum antimicrobial activity. Only two new structural types of antibiotics have entered the market in the last 40 years, linezolid and the bacterial lipopeptide daptomycin. A wide variety of bacteria produce lipopeptides, however Bacillus and Paenibacillus spp. in particular have yielded several potent antimicrobial lipopeptides. Many of the lipopeptides produced by these bacteria have been known for decades and represent a potential gold mine of antibiotic candidates. This list includes the polymyxins, octapeptins, polypeptins, iturins, surfactins, fengycins, fusaricidins, and tridecaptins, as well as some novel examples, including the kurstakins. These lipopeptides have a wide variety of activities, ranging from antibacterial and antifungal, to anticancer and antiviral. This review presents a reasonably comprehensive list of each class of lipopeptide and their known homologues. Emphasis has been placed on their antimicrobial activities, as well other potential applications for this interesting class of substances.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/med.21321

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 161

  1. 10.1128/9781555817886 · DOI · Paper page
  2. 10.1126/science.293.5536.1786 · DOI · Paper page
  3. 10.1002/anie.200600350 · DOI · Paper page
  4. 10.1016/S0140-6736(11)60401-7 · DOI · Paper page
  5. 10.1371/journal.pmed.1001104 · DOI · Paper page
  6. Pirri G, 2009, Lipopeptides as anti‐infectives: A practical perspective, Cent Eur J Biol, 4, 258
  7. 10.1146/annurev.micro.58.030603.123615 · DOI · Paper page
  8. 10.7164/antibiotics.38.1610 · doi:10.7164/antibiotics.38.1610
  9. Stansly PG, 1947, Polymyxin: A new chemotherapeutic agent, Bull Johns Hopkins Hosp, 81, 43
  10. 10.1021/jm900999h · DOI · Paper page
  11. 10.1016/j.ab.2010.10.033 · doi:10.1016/j.ab.2010.10.033
  12. 10.1002/cbic.201300496 · DOI
  13. 10.1186/cc3995 · DOI · Paper page
  14. 10.1128/AAC.02587-12 · DOI
  15. 10.1111/j.1749-6632.1949.tb27318.x · doi:10.1111/j.1749-6632.1949.tb27318.x
  16. 10.1128/AAC.00119-11 · doi:10.1128/aac.00119-11
  17. 10.1016/S0021-9673(00)92299-4 · doi:10.1016/s0021-9673(00)92299-4
  18. 10.1007/BF01901128 · doi:10.1007/bf01901128
  19. 10.7164/antibiotics.54.595 · doi:10.7164/antibiotics.54.595
  20. 10.1074/jbc.M212364200 · doi:10.1074/jbc.m212364200
  21. 10.7164/antibiotics.26.444 · doi:10.7164/antibiotics.26.444
  22. 10.7164/antibiotics.26.449 · doi:10.7164/antibiotics.26.449
  23. 10.7164/antibiotics.26.457 · doi:10.7164/antibiotics.26.457
  24. 10.7164/antibiotics.28.379 · DOI
  25. 10.1111/j.1749-6632.1974.tb43286.x · DOI
  26. 10.1016/S0021-9673(01)97597-1 · doi:10.1016/s0021-9673(01)97597-1
  27. 10.7164/antibiotics.29.1339 · doi:10.7164/antibiotics.29.1339
  28. 10.7164/antibiotics.29.516 · doi:10.7164/antibiotics.29.516
  29. 10.7164/antibiotics.29.521 · doi:10.7164/antibiotics.29.521
  30. 10.7164/antibiotics.29.1241 · doi:10.7164/antibiotics.29.1241
  31. 10.7164/antibiotics.36.634 · doi:10.7164/antibiotics.36.634
  32. 10.1128/AAC.12.6.665 · doi:10.1128/aac.12.6.665
  33. 10.7164/antibiotics.32.511 · doi:10.7164/antibiotics.32.511
  34. 10.1128/AAC.05580-11 · DOI
  35. 10.7164/antibiotics.33.186 · doi:10.7164/antibiotics.33.186
  36. Howell SF, 1950, Polypeptin, an antibiotic from a member of the Bacillus circulans group. II. Purification, crystallization, and properties of polypeptin, J Biol Chem, 186, 863, 10.1016/S0021-9258(18)56279-7 · DOI
  37. Hausmann W, 1952, Polypeptin; purification, molecular weight determination, and amino acid composition, J Biol Chem, 198, 405, 10.1016/S0021-9258(18)55594-0 · doi:10.1016/s0021-9258(18)55594-0
  38. 10.1021/jm00232a012 · DOI
  39. 10.7164/antibiotics.32.121 · doi:10.7164/antibiotics.32.121
  40. 10.7164/antibiotics.32.115 · doi:10.7164/antibiotics.32.115
  41. 10.1111/j.1574-6968.2010.02040.x · doi:10.1111/j.1574-6968.2010.02040.x
  42. 10.1186/1471-2180-12-197 · doi:10.1186/1471-2180-12-197
  43. 10.1007/s12275-011-1153-7 · doi:10.1007/s12275-011-1153-7
  44. 10.7164/antibiotics.37.1257 · doi:10.7164/antibiotics.37.1257
  45. 10.1111/j.1574-6968.1995.tb07887.x · DOI
  46. 10.1128/AEM.07782-11 · DOI
  47. 10.1128/JB.01506-12 · doi:10.1128/jb.01506-12
  48. 10.1016/S0378-1097(03)00329-X · DOI
  49. 10.1128/AEM.70.1.631-634.2004 · DOI
  50. 10.1016/S0038-0717(02)00027-5 · DOI · Paper page
  51. 10.1021/bi00612a018 · DOI · Paper page
  52. 10.1016/0040-4020(78)80138-0 · DOI
  53. 10.7164/antibiotics.36.1451 · DOI
  54. 10.1248/cpb.52.1029 · DOI
  55. 10.1016/j.febslet.2010.06.005 · DOI
  56. 10.7164/antibiotics.39.636 · DOI
  57. 10.1038/ja.2012.19 · DOI
  58. 10.1111/j.1432-1033.1985.tb09307.x · DOI
  59. 10.7164/antibiotics.37.1600 · DOI
  60. 10.7164/antibiotics.48.1095 · DOI
  61. 10.7164/antibiotics.48.1240 · DOI
  62. 10.1016/0014-5793(78)80292-0 · doi:10.1016/0014-5793(78)80292-0
  63. 10.1016/0005-2736(85)90367-0 · DOI
  64. 10.1016/0005-2736(89)90042-4 · DOI
  65. 10.1007/BF00436368 · DOI
  66. 10.7164/antibiotics.31.284 · DOI
  67. 10.1016/S0038-0717(02)00027-5 · DOI · Paper page
  68. 10.1111/j.1745-7270.2006.00157.x · DOI
  69. Pyoung K, 2010, Production of biosurfactant lipopeptides iturin A, fengycin, and surfactin a from Bacillus subtilis CMB32 for control of Colletotrichum gloeosporioides, J Microbiol Biotechn, 20, 138, 10.4014/jmb.0905.05007 · DOI · Paper page
  70. Tenoux I, 1993, Studies on bacillomycin D biosynthesis by Bacillus subtilis, Microbios, 74, 29
  71. 10.1046/j.1365-2672.2001.01290.x · DOI · Paper page
  72. 10.7164/antibiotics.35.306 · DOI
  73. 10.1128/AEM.71.8.4577-4584.2005 · DOI · Paper page
  74. 10.1016/j.jcis.2012.07.091 · DOI
  75. 10.1016/j.bbamem.2005.05.003 · DOI · Paper page
  76. 10.2174/138620703106298716 · DOI · Paper page
  77. 10.2478/s11536-008-0002-5 · DOI · Paper page
  78. Shaligram NS, 2010, Surfactin—a review on biosynthesis, fermentation, purification and applications, Food Technol Biotechn, 48, 119
  79. Kakinuma A, 1969, Determination of fatty acid in surfactin and elucidation of the total structure of surfactin, Agr Biol Chem Tokyo, 33, 973, 10.1080/00021369.1969.10859409 · DOI
  80. 10.1111/j.1432-1033.1994.tb19998.x · DOI
  81. 10.1007/BF00122922 · DOI
  82. 10.1111/j.1432-1033.1991.tb16349.x · DOI
  83. 10.1016/0006-291X(91)90637-M · DOI
  84. 10.1002/(SICI)1099-1387(199703)3:2<145::AID-PSC96>3.0.CO;2-Y · doi:10.1002/(sici)1099-1387(199703)3:2<145::aid-psc96>3.0.co;2-y
  85. 10.1006/jcis.1998.5558 · DOI · Paper page
  86. 10.7164/antibiotics.43.267 · DOI · Paper page
  87. 10.1385/ABAB:90:3:199 · DOI
  88. 10.1016/S0005-2736(99)00039-5 · DOI
  89. 10.1007/s00249-006-0091-5 · DOI · Paper page
  90. 10.1016/0021-9797(92)90319-H · doi:10.1016/0021-9797(92)90319-h
  91. 10.1111/j.1470-8744.1992.tb00218.x · DOI
  92. 10.7164/antibiotics.36.674 · DOI
  93. 10.7164/antibiotics.52.613 · DOI · Paper page
  94. 10.1006/biol.1997.0099 · DOI · Paper page
  95. Vollenbroich D, 1997, Antimycoplasma properties and application in cell culture of surfactin, a lipopeptide antibiotic from Bacillus subtilis, Appl Environ Microb, 63, 44, 10.1128/aem.63.1.44-49.1997 · DOI · Paper page
  96. 10.1128/AAC.01030-06 · doi:10.1128/aac.01030-06
  97. 10.1248/cpb.22.938 · DOI
  98. 10.1016/j.febslet.2007.01.059 · DOI · Paper page
  99. 10.1007/s10529-005-2515-1 · doi:10.1007/s10529-005-2515-1
  100. 10.1016/j.ejphar.2006.10.031 · DOI
  101. Dehghan‐Noudeh G, 2005, Isolation, characterization, and investigation of surface and hemolytic activities of a lipopeptide biosurfactant produced by Bacillus subtilis ATCC 6633, J Microbiol, 43, 272
  102. 10.1016/S0006-3495(01)75808-0 · DOI · Paper page
  103. 10.1093/protein/15.11.913 · DOI
  104. 10.1016/j.bbagen.2005.06.015 · DOI
  105. 10.1016/S0040-4039(00)77249-2 · DOI
  106. 10.7164/antibiotics.52.363 · DOI
  107. Yakimov MM, 1999, Structural characterization of lichenysin a components by fast atom bombardment tandem mass spectrometry, BBA‐Mol Cell Biol L, 1438, 273
  108. 10.7164/antibiotics.39.888 · DOI · Paper page
  109. 10.1016/j.mimet.2009.09.013 · doi:10.1016/j.mimet.2009.09.013
  110. 10.1007/s13361-012-0437-4 · DOI
  111. 10.1021/np300574v · doi:10.1021/np300574v
  112. Sang‐Cheol L, 2010, Isolation, purification, and characterization of novel fengycin S from Bacillus amyloliquefaciens Lsc04 degrading‐crude oil, Biotechnol Bioeng, 15, 246
  113. 10.7164/antibiotics.39.755 · DOI
  114. 10.1016/j.bmc.2012.04.040 · doi:10.1016/j.bmc.2012.04.040
  115. 10.1016/j.tim.2007.12.009 · DOI · Paper page
  116. 10.1128/JB.186.4.1084-1096.2004 · DOI · Paper page
  117. 10.7164/antibiotics.39.888 · DOI · Paper page
  118. 10.1007/s00438-004-1056-y · DOI · Paper page
  119. 10.1139/W07-049 · DOI · Paper page
  120. 10.1529/biophysj.107.114090 · DOI · Paper page
  121. 10.1016/j.jcis.2004.09.036 · DOI · Paper page
  122. 10.1016/j.bbamem.2011.04.008 · doi:10.1016/j.bbamem.2011.04.008
  123. 10.7164/antibiotics.50.529 · doi:10.7164/antibiotics.50.529
  124. 10.7164/antibiotics.56.716 · doi:10.7164/antibiotics.56.716
  125. 10.7164/antibiotics.39.737 · DOI
  126. Yin H, 2013, Fengycin inhibits the growth of the human lung cancer cell line 95D through reactive oxygen species production and mitochondria‐dependent apoptosis, Anti‐Cancer Drugs, 24, 587, 10.1097/CAD.0b013e3283611395 · DOI
  127. 10.7164/antibiotics.49.129 · DOI · Paper page
  128. 10.7164/antibiotics.50.220 · DOI
  129. 10.7164/antibiotics.40.1506 · doi:10.7164/antibiotics.40.1506
  130. 10.1139/w02-002 · doi:10.1139/w02-002
  131. 10.1016/j.mimet.2011.02.013 · DOI
  132. 10.1002/cmdc.201200016 · DOI
  133. 10.7164/antibiotics.25.243 · DOI
  134. 10.1007/s10658-009-9496-1 · doi:10.1007/s10658-009-9496-1
  135. 10.1007/s12600-012-0263-z · doi:10.1007/s12600-012-0263-z
  136. 10.1002/hlca.201000094 · doi:10.1002/hlca.201000094
  137. 10.1021/np000169q · DOI · Paper page
  138. 10.1007/s00253-012-4181-2 · DOI
  139. 10.7164/antibiotics.25.304 · doi:10.7164/antibiotics.25.304
  140. 10.7164/antibiotics.25.147 · doi:10.7164/antibiotics.25.147
  141. 10.7164/antibiotics.25.309 · DOI
  142. 10.7164/antibiotics.28.60 · doi:10.7164/antibiotics.28.60
  143. 10.7164/antibiotics.28.56 · doi:10.7164/antibiotics.28.56
  144. 10.7164/antibiotics.28.764 · doi:10.7164/antibiotics.28.764
  145. 10.7164/antibiotics.29.1281 · doi:10.7164/antibiotics.29.1281
  146. 10.7164/antibiotics.29.1275 · doi:10.7164/antibiotics.29.1275
  147. 10.7164/antibiotics.29.1268 · doi:10.7164/antibiotics.29.1268
  148. 10.7164/antibiotics.32.313 · doi:10.7164/antibiotics.32.313
  149. 10.7164/antibiotics.31.652 · doi:10.7164/antibiotics.31.652
  150. 10.7164/antibiotics.32.305 · doi:10.7164/antibiotics.32.305
  151. 10.1021/ja3089229 · DOI
  152. 10.1002/cbic.201300595 · doi:10.1002/cbic.201300595
  153. 10.1021/jm401779d · doi:10.1021/jm401779d
  154. 10.1016/j.ccc.2007.12.003 · doi:10.1016/j.ccc.2007.12.003
  155. 10.1093/jac/dkm357 · DOI · Paper page
  156. 10.3389/fmicb.2013.00332 · DOI
  157. 10.1016/j.micres.2012.11.004 · DOI
  158. 10.1016/S0923-2508(97)87647-4 · DOI
  159. 10.1007/s11274-008-9752-0 · doi:10.1007/s11274-008-9752-0
  160. 10.1002/cbic.201402024 · DOI
  161. Clinical and Laboratory Standards Institute Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard‐ninth edition and performance standards for antimicrobial susceptibility testing2013;33(1):142–143.

Cited by

See all 474

Metadata

Authors
Cochrane, S. A., & Vederas, J. C.
Venue
Medicinal Research Reviews
Publisher
Wiley
Published
2014-05-28
Volume
36
Issue
1
Pages
4-31
ISSN
  • 0198-6325 (ISSN-L)
  • 1098-1128
OpenAlex
W2137992445
Cited by
474
References
0
FWCI
17.10
Type
journal article
Language
en
Open access
closed
Funders
  • Natural Sciences and Engineering Research Council of Canada
  • Griffith Laboratories Canada; Canada Research Chair in Bioorganic and Medicinal Chemistry

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Lipopeptides from Bacillus and Paenibacillus spp.: A Gold Mine of Antibiotic Candidates. https://app.cochat.ai/papers/10.1002/med.21321
The paper
Cochrane, S. A., & Vederas, J. C. (2016). Lipopeptides from Bacillus and Paenibacillus spp.: A Gold Mine of Antibiotic Candidates. Medicinal Research Reviews. https://doi.org/10.1002/med.21321

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.